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Bacteria can be found in two distinct states: planktonic or as part of a sessile 
biofilm. While planktonic, free-floating bacteria are moderately easy to eradicate with 
antibiotics, bacteria in biofilms are not. Bacterial biofilms are tightly packed together, 
making it difficult for antibiotics to pass through the film and eliminate the bacteria; this 
antibiotic resistance makes it difficult to treat many bacterial infections. To try to 
decrease the antibiotic resistance of bacterial biofilms, this study utilized a microparticle 
spacer to create distance between cells in biofilms. The microparticle spacer was made by 
annealing Dynabead magnetic beads to Cholesterol-containing DNA; the Cholesterol on 
the spacer could bind to the lipid bilayer of bacteria. The spacer was mixed with various 
proportions of Escherichia coli K-12 wild-type and analyzed with fluorescence 
microscopy to determine binding affinity between the spacer and bacteria. Binding was 
quantified both visually and computationally, and the two methods were compared to 
determine accuracy. The spacers and bacteria showed high levels of binding, with over 
84.8% of all spacers bound to bacteria according to the visual method. 13.3% difference 
was determined between the two methods; therefore, the computational method still 
needs improved precision and accuracy before it is used consistently. Due to a 
demonstrated high binding affinity, we hypothesize that this microparticle spacer could  
successfully add space between bacteria in biofilms.  









 Bacterial biofilms are formed when free-swimming bacteria attach to a substratum 
in moist environments.1 According to the National Institutes of Health, around 80% of 
bacterial infections in humans involve biofilm-associated microorganisms.2 Some 
common biofilm locations in humans include along the gastrointestinal tract and on 
artificial surfaces located in the body, such as implants.3 As a biofilm, sessile bacteria 
have an increased tolerance for antibiotics. The cells in these biofilms are closely packed, 
which makes it harder for antibiotics to flow through the biofilm and treat bacteria.  The 
insufficient nutrients and space provided to bacteria in biofilms cause the bacteria to 
grow slowly, increasing resistance. Another reason biofilms are highly resistant to 
antibiotics is because multiple species of bacteria can grow in one biofilm. Biofilms 
contain heterogeneous and spatially stratified structures, which allow chemical gradients 
in the concentration of nutrients to find individual niches for multiple species of bacteria 
to live together in the same biofilm. The different species of bacteria can transfer 
resistance genes to the species surrounding them, increasing the overall resistance.4 Since 
bacterial biofilms have such a high resistance to antibiotics, there is interest in finding 
new methods to decrease tolerance levels and eradicate the biofilms. These methods 
could help eliminate bacterial infections. 
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Many researchers have analyzed how to disperse or prevent the buildup of 
bacterial biofilms. One method of dispersal that was discovered was sudden changes in 
nutrient availability, such as changes in carbon and oxygen levels. Hunt et al found that 
biofilms under continuous-flow conditions underwent dispersal in response to both 
sudden decreases and increases in carbon substrate availability.5 Meanwhile, Applegate 
and Bryers discovered that oxygen-limited biofilms demonstrated significantly lower 
shear removal rates and significantly greater biofilm dispersal rates compared to biofilms 
in oxygen-rich conditions.6 Other techniques to eradicate these biofilms that have been 
studied are controlling quorum sensing, implementing surface coatings, and using small 
molecules and nano-scaffolds.7,8,9,10 Despite these proposed methods, the efficiency of 
eliminating the biofilm and decreasing resistance can still be improved.  
In contrast to past studies, this study aims to control the biofilm instead of destroy 
it or prevent its buildup. This new outlook may answer many unknown questions 
regarding biofilms, as well as find a more effective way to make them less resistant to 
antibiotics. To control the biofilm, the distance between the bacteria will be regulated. 
Microparticles of equal size, Dynabeads, will be used as "spacers" that bind to bacteria 
and create equal separation between the cells. In order for these spacers to stick to the 
bacteria, an “effector” must be applied to the outside of the microparticles. The "effector" 
will be made from DNA with a Cholesterol attachment, and it will allow the spacer to 
attach to the lipid bilayer of the bacteria. This study will contribute to the area of bacteria 
biofilms by discovering a new, more effective, and highly innovative way to decrease the 




METHODS AND MATERIALS 
 
 For this project, two strands of synthetic DNA (Integrated DNA Technologies) 
were annealed to each other, and then they were annealed to Dynabead Oligo (dT)25-
61002 (ThermoFisher Scientific) microparticles to form the microparticle spacer (see 
Figure 1). One strand of the synthetic DNA, the splint DNA, consisted of a tail of A 
nucleotides that could bind to the Dynabead’s strand of T nucleotides. The other strand, 
the cholesterol DNA, consisted of a cholesterol attachment, a Texas Red fluorophore, and 
a strand of nucleotides complementary to the non-A tail of the splint DNA. 
Complimentary nucleotide sequences between the two strands of DNA and the Dynabead 
allowed for binding to occur. Agarose slides were created, and the E. coli K-12 wild-type 
bacteria and Bead-DNA complex were added to the slides. The slides were viewed using 
fluorescence microscopy and analyzed both visually and computationally. 
 
Figure 1. Schematic of microparticle spacer: Dynabead, DNA, and cholesterol attachment. 
Annealing the Two Strands of DNA 
 To anneal the two strands of DNA, a 100 mM solution of cholesterol DNA was 
made by combining 13 nmol of the cholesterol DNA with 130 μL of nuclease-free water 
and vortexing on the mixer. The cholesterol DNA solution container was wrapped in 
aluminum foil in order to protect the red color of the Texas Red fluorophore from 
decreasing in brightness. A 100 mM solution of splint DNA was also made by combining 
11.3 nmol of splint oligo with 113 μL of nuclease-free water and vortexing on the mixer. 
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Next, 8 μL of the splint solution and 4 μL of the cholesterol solution were placed in a 
PCR tube. Using a thermocycler, the temperature was set at 80 ℃ for 3 minutes, and then 
the temperature was decreased by 1 degree/min until 4 ℃ was reached. 
Washing the Dynabeads 
 Before using the Dynabeads for the microparticle spacer, the beads needed to be 
washed. To wash the beads, 40 μL of beads and 1 mL of DNA annealing buffer (10 mM 
Tris, pH 7.5-8.0, 50 mM NaCl, and 1 mM EDTA) were placed in a microcentrifuge tube. 
The microcentrifuge tube was placed on a Dynabead MPC-S magnetic particle 
concentrator (ThermoFisher Scientific), and the MPC-S separated the beads from the 
supernatant. The supernatant was removed from the tube, and the beads were 
resuspended in 40 μL of the DNA annealing buffer. The beads were mixed on a vortex 
mixer to ensure a homogeneous solution. 
Creating the Microparticle Spacer: Annealing Dynabeads to the DNA 
 To determine the effect of adding an effector to the spacer, two different 
concentrations of beads to DNA were used. In 2 separate PCR tubes, the mixtures of 10 
μL of beads (control without the effector) and 10 μL of beads with an added 2 μL of 
DNA (spacer with the effector) were created. Using a thermocycler, the mixtures were 
heated up to 42 ℃ and left for 5 minutes. Then, they were brought back down to 4 
degrees at a rate of 1 degree/min. Now, the microparticle spacer had been successfully 
created. 
Making Agarose Slides 
 To make agarose slides, 5 mL of EZ Rich growth medium was added to a test 
tube through the usage of a sterilized 25 mL pipette, and then the pipette was properly 
discarded in a sharps container. Next, 0.1 grams of agarose was properly weighed and 
added to the test tube. The EZ growth medium and the agarose were mixed to form a 2% 
agarose solution by placing in a lab oven around 80 ℃ for 20 minutes. After the solution 
was properly mixed, one sticky side was removed from each of the two microfilms, the 
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sticky sides were placed together, and small squares the width of the microscope slides 
were cut out of the microfilms. A circle was cut out of the center of each microfilm 
square by wrapping a piece of paper around each square and removing the circle with a 
hole puncher. Then, one of the sticky sides of the square was removed, and the square 
was placed on center of the microscope slide. The agarose solution was pipetted into the 
center, hole-punched region of the circle until it overflowed, and a glass cover was 
quickly placed on top. After letting dry for around 10 minutes, the slide was ready for the 
bacteria and microparticle spacers to be added.  
Combining the Bacteria and the Microparticle Spacer 
 After making the slides, 1 μL of each of the 2 different bead-DNA mixtures were 
combined with 10 μL of E. coli bacteria in separate test tubes. The test tubes were 
incubated for 10 minutes, and 2 μL of each of the solutions were added to separate 
agarose slides. Then, the slides were placed under a Leica inverted microscope for 
viewing and recording with fluorescence microscopy. For each slide, 100 spacers were 
imaged and recorded. 
Analyzing Microscopy Images Visually 
 After recording the images, the percentage of microparticle spacers bound to 
bacteria was analyzed visually. For each image, the number of spacers, which glow red 
under fluorescence, the number of bacteria, which glow green, and the number of spacers 
bound to one or more bacteria were counted. The percentage of spacers bound to bacteria 
was calculated by dividing the number of spacers bound to bacteria by the total number 
of spacers in the image. Afterwards, a two-sample t-test assuming equal variances with 
alpha level 0.05 was applied to the two conditions to determine whether they are 
significantly different. 
Analyzing Microscopy Images Computationally 
 To determine the number of beads bound to bacteria more efficiently, a 
computational method was generated in MATLAB. This code used image segmentation 
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procedures to locate and quantify the number of spacers and bacteria in the image based 
on color. To find the number of spacers, a red threshold was created by separating the 
image into three separate RGB channels and identifying all the regions of the image that 
were present in the red channel. When using this same threshold with the original image, 
only areas of the image with red colorization above this threshold, the same regions that 
were seen in the red channel, were shown in the image. Therefore, these areas were 
identified as the spacers. Then, boundaries were found around each spacer and the 
number of separate spacers was counted. This process was repeated for the bacteria with 
a green color threshold instead. Afterwards, sub-images were created around each spacer 
and the number of bacteria in each sub-image was quantified to determine the number of 
bacteria bound to each spacer. The number of spacers discovered in each image using the 
computational method was compared to the number of spacers discovered using the 







 After placing the two slides under the microscope, successful images were 
obtained (see Figure 2). For each image, the microparticle spacer fluoresced red, and 
when the effector was present, a darker ring of red could be seen around the edge of the 
spacer, showing that the cholesterol successfully bound to the Dynabead. In contrast, the 
E. coli bacteria fluoresced green, and attachment between the spacers and bacteria could 
be seen. 
 
Figure 2. Image of microparticle spacers and bacteria under fluorescence. The spacers are shown in red 
while the bacteria are shown in green. 
Data Analysis 
 Once the number of spacers and bacteria were calculated visually, the average 
percentage of microparticle spacer binding was found for both conditions. For the 
microparticle spacers without effector, 2.90% ± 1.85% of the spacers were bound to 
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bacteria. For the microparticle spacers with effector, 84.8% ± 0.14% of the spacers were 
bound to bacteria (see Figure 3). To test significance, a two-sample t-test with alpha level 
0.05 was applied using the two data sets. The two-sample t-test revealed a p-value of 
0.000255. 
 
Figure 3. Microparticle Spacer Type vs Percentage of Spacers Bound to Bacteria. A two-sample t-test 
revealed a p-value of 0.000255 between the groups, less than the alpha level of 0.05. This small p-value is 
indicated by the two asterisks between the groups. The error bars represent the standard deviations of the 
two groups. 
Computational Analysis 
 When running images through the computational code, red spacers and green 
bacteria were successfully separated and identified, and boundaries were distinguished 
around each individual particle (see Figure 4). In regions where the spacers were 
clumped together and too close to identify as individual spacers, the number of spacers in 
the clump were counted based on the total area of the clump. The area of one spacer was 





Figure 4. Images of the Bacteria and Spacers Utilized in the Computational Code. From left to right: a) 
An image of microparticle spacers and bacteria output from the microscope. b) The same image containing 
only the red spacers with blue boundaries highlighting the edge of each spacer. c) The same image 
containing only the green bacteria with blue boundaries highlighting the edge of each bacterium. 
 
 Percent difference between the computational method and the visual method was 
calculated as 13.3%. Images with lighting issues, such as dark regions where there was 







 To determine the significance of the effector, a t-test was performed between the 
microparticle spacer with effector and the microparticle spacer without effector. The null 
hypothesis for this test was that the means of the two groups were the same. The t-test 
revealed a p-value of 0.000255 at a 0.05 confidence interval. Therefore, the null 
hypothesis was rejected, and the two groups were shown to be significantly different. The 
effector created a significant increase in the percentage of microparticle spacers to 
bacteria. Overall, such a high percentage of binding, 84.8%, for the microparticle spacer 
with effector proved that this spacer effectively binds to bacteria. 
 For the computational method and visual method comparison, the percent 
difference resulted in 13.3%. This percent difference is relatively high. The visual 
method is assumed to be accurate due to human error being the only source of error; 
therefore, the computational method needs to be further altered to be more precise and 
accurate. 
Error, Limitation, and Unexpected Results 
 One possible error is that the number of microparticle spacers used in each trial 
may have been inconsistent. To minimize this error, the microparticle spacers were mixed 
in the DNA annealing buffer using a mixer every time before extraction for data 
collection. This mixing prevented the spacers from collecting at the bottom of the buffer 
and made the concentration of spacers more consistent throughout the buffer. Also, when 
collecting for imaging, the spacers were always extracted from the center of the PCR tube 
to try to keep concentration consistent.  
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 The computational method has many potential sources of error. Possible errors 
with the computational method are too small boundaries being identified around the 
spacers and the code incorrectly recognizing color regions, preventing some bacteria and 
spacers from being counted. The poor resolution of some of the images made it hard for 
some of the images to be analyzed; some spacers did not appear red, so they were not 
counted by the code. 
 One limitation of this study was the sample size of the data. Since the data was 
analyzed visually and then compared to the computational method, the number of images 
that could be analyzed by hand was limited due to the length of time it takes a human to 
analyze each image. Once the computational method is reliable enough to be used as the 
sole analysis method, the number of images that can be studied will increase. This will 
improve reliability by producing a greater sample size. 
Future Work 
 Moving forward, the microparticle spacer will be implemented in bacterial 
biofilms to test for eradication levels. To test its effect, spacers will be added to the 
biofilms through cholesterol binding, and then, antibiotics, such as ampicillin and 
gentamicin, will be ran through. The percentage of bacteria in the biofilm before and after 
the application of antibiotics will be compared for both biofilms containing spacers and 
biofilms not containing spacers. Due to the spacer’s demonstrated high binding affinity, 
we hypothesize that a high percentage of bacteria will be eradicated in the biofilms 
containing microparticle spacers. 
 The computational method will continue to be edited to improve precision and 
accuracy. Images with higher concentrations of bacteria and spacers will be tested to 
determine the effect of particle concentration on the code’s accuracy. During eradication 
testing, the code will be used with images taken over a period of time, so the 
computational time per image will need to be minimized so a higher number of images 
does not take an exceedingly long period of time to analyze. 
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 If eradication testing is successful, the microparticle spacer design may be 
changed to include a protein that can bind to the surface of specific bacteria instead of a 
cholesterol. Using a protein would allow for higher specification, which is needed before 





 Bacterial biofilms are tightly packed regions of bacteria that are difficult to treat 
with antibiotics due to their density and increased tolerance to antibiotics. Our 
microparticle spacer can successfully attach to 84.8% of the bacteria in the biofilms and 
decrease the tolerance of these biofilms, allowing them to be eradicated more easily. 
Compared to other methods of biofilm prevention and dispersion, our method is more 
innovative and potentially more successful at eradicating biofilms depending on the 
results of our oncoming eradication studies.  Along with use for biofilm eradication, our 
microparticle spacer may also be used in diagnostic and therapeutic technology.  To test 
its diagnostic or therapeutic properties, a Dynabead MPC-S magnetic particle concentrator 
could be used with the microparticle spacers. Since the Dynabeads are magnetic, the MPC-S 
could use magnetic force to accumulate all the microparticle spacers to one region, and this 
desired region containing the microparticle spacers could be removed from the rest of the 
sample. Since these spacers would be attached to bacteria, this accumulation could allow a 
larger percentage of bacteria to be analyzed at once, making it easier to diagnose the microbe 
and bacterial infection. This method of accumulating bacteria, or possibly viruses, could also 
make it easier to remove blood-borne illnesses from blood during dialysis. Once eradication 
studies have been completed and the microparticle spacer’s success is determined relative to 
current work in the field, the microparticle spacer may be tested for diagnostic and 
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